Form D · Biotechnology
Health Elements, LLC
Sandpoint, ID · CIK 0001561638
Offering snapshot reported Dec 12, 2012 · SEC filing
- Reported sold
- $4M Offering amount: $15M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 30, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 12, 2012 | Initial | $4,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-188229
Source: Form D, filed Dec 12, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Houman Arasteh | Director |
| Scott Bowen | Director |
| Riccardo Braglia | Director |
| Hooman Fakki | Director |
| J. Fritz Geer | Director |
| Daniele Giavini | Director |
| Paul F. Jacobson | Director, Executive |
| James B. La Valle | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
25820 Highway 2 West
Sandpoint, ID, 83864
Sandpoint, ID, 83864